During the 90-day period following randomization, any signs of infection, such as fever, in patients receiving either fluconazole or placebo triggered a comprehensive check-up, including C-reactive protein, procalcitonin, G test, GM test, chest CT scan, sputum culture, blood culture, and BALF NGS testing to identify pathogens. Here, CRP is linked to infection.